These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 24008352)
1. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. Leitl MD; Onvani S; Bowers MS; Cheng K; Rice KC; Carlezon WA; Banks ML; Negus SS Neuropsychopharmacology; 2014 Feb; 39(3):614-24. PubMed ID: 24008352 [TBL] [Abstract][Full Text] [Related]
2. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391 [TBL] [Abstract][Full Text] [Related]
3. Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats. Leitl MD; Potter DN; Cheng K; Rice KC; Carlezon WA; Negus SS Mol Pain; 2014 Sep; 10():62. PubMed ID: 25245060 [TBL] [Abstract][Full Text] [Related]
4. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Heidbreder CA; Schenk S; Partridge B; Shippenberg TS Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129 [TBL] [Abstract][Full Text] [Related]
5. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats. Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. Leitl MD; Negus SS Behav Pharmacol; 2016 Jun; 27(4):364-76. PubMed ID: 26588213 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats. Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297 [TBL] [Abstract][Full Text] [Related]
8. Effects of ketoprofen, morphine, and kappa opioids on pain-related depression of nesting in mice. Negus SS; Neddenriep B; Altarifi AA; Carroll FI; Leitl MD; Miller LL Pain; 2015 Jun; 156(6):1153-1160. PubMed ID: 25827812 [TBL] [Abstract][Full Text] [Related]
10. Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats. Negus SS; O'Connell R; Morrissey E; Cheng K; Rice KC J Pharmacol Exp Ther; 2012 Mar; 340(3):501-9. PubMed ID: 22128346 [TBL] [Abstract][Full Text] [Related]
11. Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K+ induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats. Escobar Adel P; Cornejo FA; Andrés ME; Fuentealba JA Neurochem Int; 2012 Mar; 60(4):344-9. PubMed ID: 22306346 [TBL] [Abstract][Full Text] [Related]
12. Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats. Legakis LP; Karim-Nejad L; Negus SS Psychopharmacology (Berl); 2020 Jul; 237(7):2201-2212. PubMed ID: 32382785 [TBL] [Abstract][Full Text] [Related]
13. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors. Lazenka MF; Freitas KC; Henck S; Negus SS J Pharmacol Exp Ther; 2017 Jul; 362(1):14-23. PubMed ID: 28411257 [TBL] [Abstract][Full Text] [Related]
14. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Chartoff E; Sawyer A; Rachlin A; Potter D; Pliakas A; Carlezon WA Neuropharmacology; 2012 Jan; 62(1):167-76. PubMed ID: 21736885 [TBL] [Abstract][Full Text] [Related]
15. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action. Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138 [TBL] [Abstract][Full Text] [Related]
16. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Todtenkopf MS; Marcus JF; Portoghese PS; Carlezon WA Psychopharmacology (Berl); 2004 Apr; 172(4):463-70. PubMed ID: 14727002 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. Chefer VI; Shippenberg TS Eur J Neurosci; 2006 Jan; 23(1):229-38. PubMed ID: 16420432 [TBL] [Abstract][Full Text] [Related]